IHR in Recent News
May 2021
-
KP Colorado Twitter | May 21
Mabel Peters, BS, CCRP, an operational research specialist in clinical trials for the Institute for Health Research, has been recognized by her colleagues as a KP Colorado Rock Star. She provides patient-centered care and shows a strong passion for research. https://twitter.com/KPcolorado/status/1395771613220462594
-
The Verge | May 15
Matthew F. Daley, Kaiser Permanente pediatrician and senior clinician investigator at our Institute for Health Research is quoted on how the availability of vaccines is leading to reduced deaths and reduced cases nation-wide. https://www.theverge.com/2021/5/15/22437290/vaccines-teens-covid-19-antivirus
April 2021
-
Colorado Sun | April 28
Matthew F. Daley, MD, Kaiser Permanente pediatrician and senior clinician investigator at the Institute for Health Research offers important insight on VAERS, a federal vaccine side-effect monitoring system, as it relates to the COVID-19 vaccines. https://coloradosun.com/2021/04/28/coronavirus-vaccine-common-side-effects/
-
HealthDay | April 19 ,
BreastCancer.org | April 12 ,
Medical Life Sciences | April 12 and
Philly Voice | April 12
Continuing Coverage: Heather Feigelson, PhD, MPH, Kaiser Permanente senior investigator at the Institute for Health Research had a recent study published in the Journal of the National Cancer Institute. The research suggests breast cancer survivors who are overweight have a statistically significant increased risk of developing second primary cancers.
https://consumer.healthday.com/4-19-in-breast-cancer-survivors-obesity-raises-odds-for-cancers-return-2652504507.html
https://www.breastcancer.org/research-news/risk-of-second-cancer-goes-up-as-weight-increases
https://www.news-medical.net/news/20210412/Breast-cancer-survivors-with-excess-body-weight-at-increased-risk-of-developing-second-cancer.aspx
https://www.phillyvoice.com/breast-cancer-weight-loss-obesity-risk/
-
Yahoo! News | April 5 and
Grand Junction Daily Sentinel | April 5
Heather Feigelson, PhD, MPH, Kaiser Permanente senior investigator at the Institute for Health Research had a recent study published in the Journal of the National Cancer Institute. The research suggests breast cancer survivors who are overweight have a statistically significant increased risk of developing second primary cancers.
https://finance.yahoo.com/news/weight-linked-risk-second-cancer-140000402.html?guccounter=1
https://www.gjsentinel.com/news/colorado/weight-linked-to-risk-of-second-cancer-after-breast-cancer/article_2230bb8c-2cea-5416-a807-fbad15247aac.html
March 2021
-
JAMA Network Open | March 26
Research from John Steiner, MD, MPH, senior clinical investigator at Kaiser Permanente’s Institute for Health Research suggests patients who received many automated messages from medical providers were more likely to opt out of receiving future messages. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777872
-
about.kaiserpermanente.org | March 5
IHR research investigator, Dr. Cheryl Kelly, donates $10,000 2020 David Lawrence Community Service Award to GrowHaus. Cheryl is the 2020 David Lawrence Community Service Award winner for KPCO. She has served on the GrowHaus board since 2018 and was recently voted to the executive committee of the board. Watch her video and learn more about the GrowHaus and the difference they are making in the Globeville and Elyria-Swansea community. https://about.kaiserpermanente.org/community-health/news/cheryl-kelly-names-the-growhaus-as-recipient-of-10k-award
-
CNN | March 1
The FDA granted emergency use authorization for the Johnson & Johnson vaccine on Saturday. Matthew F. Daley, MD, Kaiser Permanente pediatrician and senior investigator at the Institute for Health Research is quoted in several national publications on how this will help increase vaccine supply across the US. Dr. Daley is a panel member for the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. https://us.cnn.com/2021/02/28/health/johnson-and-johnson-acip-meeting/index.html
February 2021
-
Washington Post | February 28
The FDA granted emergency use authorization for the Johnson & Johnson vaccine on Saturday. Matthew F. Daley, MD, Kaiser Permanente pediatrician and senior investigator at the Institute for Health Research is quoted in several national publications on how this will help increase vaccine supply across the US. Dr. Daley is a panel member for the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. https://www.washingtonpost.com/health/2021/02/28/johnson-and-johnson-vaccine-cdc-recommendation/
-
Wall Street Journal | February 28
The FDA granted emergency use authorization for the Johnson & Johnson vaccine on Saturday. Matthew F. Daley, MD, Kaiser Permanente pediatrician and senior investigator at the Institute for Health Research is quoted in several national publications on how this will help increase vaccine supply across the US. Dr. Daley is a panel member for the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. https://www.wsj.com/articles/j-j-covid-19-vaccine-endorsed-by-cdc-advisers-11614544468
October 2020
-
The Colorado Springs Business Journal | October 19
Matthew F. Daley, MD, KP pediatrician and senior clinician investigator at KP’s Institute for Health Research writes a guest column on the importance of vaccinations. https://www.csbj.com/online_features/health_and_wellness/don-t-wait-vaccinate-flu-season-and-covid-19-a-dangerous-double-threat/article_db7048f0-13ec-5321-896e-e32252352767.html
-
5280 Magazine | October 14
In a paid article, Kaiser Permanente's Institute for Health Research is profiled for its work on COVID-19 treatments and studies. Claudia Steiner, MD, executive medical director of Kaiser Permanente's Institute for Health Research (IHR) and Rebecca Boxer, MD, director of clinical trials for the IHR are quoted. https://paidposts.5280.com/kaiser-oct2020/
-
Health Day | October 14
A new study from Jason Glanz, PhD, senior investigator at Kaiser Permanente's Institute for Health Research suggests when parents have concerns about the safety of childhood vaccinations, it can be tough to change their minds. https://consumer.healthday.com/kids-health-information-23/immunization-news-405/it-s-tough-to-change-the-minds-of-vaccine-hesitant-parents-study-finds-762104.html
-
Denver Post | October 8
Matthew F. Daley, MD, KP pediatrician and senior clinician investigator at KP's Institute for Health Research writes a guest column on the importance of vaccinations. https://yourhub.denverpost.com/blog/2020/09/dont-wait-vaccinate/268369/
August 2020
-
New York Times | August 20
Researchers are testing an experimental drug to halt sudden COVID-19 outbreaks in nursing homes. Rebecca Boxer, MD, medical director of clinical trials at KP’s Institute for Health Research is quoted throughout the article. https://www.nytimes.com/2020/08/20/health/coronavirus-nursing-homes.html)
May 2020
-
Denver Post | May 17
Rebecca Boxer, MD, KPCO director of clinical trials at the Institute for Health Research is quoted on a new consortium that is participating in an experimental therapy to treat COVID-19 symptoms—convalescent plasma donation—and how KPCO is involved. (click for print version: https://www.denverpost.com/2020/05/17/colorado-plasma-coronavirus-covid-treatment/)
-
Queering Mental Health | May 6, 2020
Leslie Wright, KPCO Institute for Health Research community research liaison and project manager was part of a virtual roundtable discussing mental health needs in the LGBTQ+ community. Leslie was quoted on the mental health needs of seniors. (page 22: https://issuu.com/outfrontcolorado/docs/envision_05.06.2020_yp)
April 2020
-
Colorado Parent | April 29
A first-hand account of postpartum depression and an in-depth look at the help available. Joyce Gottesfeld, MD, KPCO Ob-GYN and Arne Beck, PhD., KPCO senior investigator at the Institute for Health Research are quoted extensively. KPCO’s peer-to-peer postpartum depression help program is mentioned. https://www.coloradoparent.com/the-new-moms-guide-to-postpartum-depression/)
-
KOAA News-NBC (SoCO) | April 19
Rebecca Boxer, MD, KPCO director of clinical trials is quoted on our KPCO’s efforts to deliver a new experimental therapy through convalescent plasma donations. https://www.koaa.com/news/coronavirus/medical-professions-work-together-for-plasma-program)
-
5280 Magazine | April 16
Rebecca Boxer, MD, KPCO medical director of clinical trials and geriatrician provides information on an experimental therapy called convalescent plasma donation and how KPCO is part of a state-wide consortium gathering information on these donations. https://www.5280.com/2020/04/can-blood-products-donated-by-covid-19-survivors-treat-the-disease/)
-
ABC Denver Channel 7 | April 12
Wendee Gozansky, MD, a lead physician expert in the EOC, KPCO geriatrician, and CPMG VP & Chief Quality Officer discusses the importance of staying connected with the senior population during the COVID-19 pandemic. https://kp.qumucloud.com/view/Kxbks3NbvTD#/
-
Fox 31 | April 4
Wendee Gozansky, MD, a lead physician expert in the EOC, KPCO geriatrician, and CPMG VP & Chief Quality Officer discusses the importance of staying connected with the senior population during the COVID-19 pandemic. https://kp.qumucloud.com/view/UcDOoWoaoqc#/
-
Channel 2 News | April 4
Wendee Gozansky, MD, a lead physician expert in the EOC, KPCO geriatrician, and CPMG VP & Chief Quality Officer discusses the importance of staying connected with the senior population during the COVID-19 pandemic. https://kp.qumucloud.com/view/8IIrXGB0WR4#/
-
Colorado Public Radio | April 2
Wendee Gozansky, MD, KPCO geriatrician and CPMG VP & Chief Quality Officer discusses KPCO’s shift to ensure physicians are available in urgent, ER, and hospital settings for potential COVID influx. https://www.cpr.org/2020/04/02/specialists-primary-care-doctors-retrain-for-hospital-frontlines-as-colorado-coronavirus-cases-mount/)